Its utility as a backbone therapy, with a broad range of risk reduction and treatment benefits may erode the market potential of newer, indication-specific therapies, even in areas where semaglutide is not yet explicitly approved, but initial trial readouts show promising results, e.g
If this process is inhibited, for example by thiamine deficiency, lactate will build up
#clinicalresearch #GLP1 #healthtech #obesity #virtualcare Noom GLP-1 Support Maintains Weight Loss New observational analyses suggest patients who used Noom's GLP-1focused #digitalhealth support programmes maintained most of their #weightloss after stopping medication, with roughly three times lower weight regain than published benchmarks
In such cases, I strongly recommend Glutathione, Choline + Inositol
H.LudwigB
Compounded versions have not gone through the FDA approval process, and there is not enough clinical data to confirm that oral tirzepatide works as effectively as the injectable form